Anemia is defined as low hemoglobin concentration resulting in a decrease in oxygen carrying capacity of blood according to WHO Hb level of 11gms/dl if consider as anemia. This study is compare the safety and efficacy of FCM injection and blood transfusion in anemic pregnant woman after 20 weeks of gestation.
Method: It is a descriptive study 50 pregnant woman with Hb of 7.5 to 9gms as infused with inj. FCM (500mg/10ml) consider as Group A, Group B 50 Anemic pregnant woman with hemoglobin of 7.5 to9gms was transfused with blood. Hb, ferritin, PCV, WBC; peripheral smear was monitored in both groups after 3 weeks of infusion, after delivery, 6 weeks after delivery.
Result: FCM infusion significantly increase HB, PCV, Ferritin, peripheral smear LEVELS (P<0.01) from pre infusion Hb, PCV ferritin, peripheral smear and the same investigation was measured after 3 weeks after infusion, immediately after delivery, 6wks after delivery the significant improvement in Hb, ferritin PCV, peripheral there is no significant systemic and local reaction occurred in following FCM infusion. But there is no improvement in WBC level. In blood transfusion groups there is no much significant increase in HB, PCV, Peripheral smear. But there is significant improvement in WBC level as compared to FCM injection.
Conclusion: Our study statically concluded that FCM improve Hb Ferrtin PCV Peripheral smear value in anemic pregnant woman. Blood Transfusion also increase Hb, Ferrtin, PCV, Peripheral smear levels but not as significant as FCM.